Adult Clinical Trials

Endocrine Cancers

If you would like to inquire about all open trials, please contact 919.681.4800.

6 trials identified.

Tissue and Serum Acquisition Protocol for Molecular Analysis and Cell Culture in Patients Undergoing Parathyroid Surgery.
Phase: N/A
Sponsor: Internal Investigator Initiated Non-therapeutic/Non-interventional
Principal Investigator: Julie Ann Sosa
Contact: Endocrine Oncology Clinical Research Office
Phone: 919 .­­­681.1478
Reference Number: 00046210

Thyroid Cancer and Polybrominated Diphenyl Ether (PBDE) Exposure
Phase: N/A
Sponsor: Internal Investigator Initiated Non-therapeutic/Non-interventional
Principal Investigator: Julie Ann Sosa
Contact: Endocrine Oncology Clinical Trials Office
Phone: 919.681.1478
Reference Number: 00050074

A Phase 2 Study to Investigate the Safety and Activity of Fosbretabulin Tromethamine (CA4P) in the Treatment of Well-Differentiated, Low-to- Intermediate-Grade Unresectable, Recurrent or Metastatic Gastrointestinal Neuroendocrine Tumors/Carcinoid (GI-NET) with Elevated Biomarkers
Phase: Phase II
Sponsor: Commercial / Industry (for-profit group) initiated
Principal Investigator: Julie Ann Sosa
Contact: Endocrine Oncology Research Office
Phone: 919.681.4800
Reference Number: 00054331
View this trial at ClinicalTrials.gov

Randomized Double-Blind Phase II Study of Radioactive Iodine (RAI) in Combination with Placebo or Selumetinib for the Treatment of RAI-Avid Recurrent/Metastatic Thyroid Cancers
Phase: Phase II
Sponsor: Commercial / Industry (for-profit group) initiated
Principal Investigator: Julie Ann Sosa
Contact: Endocrine Oncology Clinical Research Office
Phone: 919. ­681.1478
Reference Number: 00059332
View this trial at ClinicalTrials.gov

RIFTOS MKI - Radioactive Iodine reFractory asymptomatic patients in differentiated Thyroid cancer an Observational Study to assess the use of MultiKinase Inhibitors
Phase: N/A
Sponsor: Commercial / Industry (for-profit group) initiated
Principal Investigator: Julie Ann Sosa
Contact: Kristen Linney, RN
Phone: 919.684.8239
Reference Number: 00064729

An Open label single arm multi center phase 2 trial of lenvatinib for the treatment of anaplastic thyroid cancer (ATC).
Phase: Phase II
Sponsor: Commercial / Industry (for-profit group) initiated
Principal Investigator: Julie Ann Sosa
Contact: Endocrine Oncology Clinical Research Office
Phone: 919.681.1478
Reference Number: 00074190
View this trial at ClinicalTrials.gov